Furthermore, a previous report indicating the role of DEPDC1B in pancreatic cancer development through targeting the Akt/Gsk3b/Snail pathway also provides support for the alleviation of DEPDC1B overexpression-induced effects by CDK1 knockdown (41). This evidence concerns the gene DEPDC1B and pancreatic neoplasm.